Introduction {#sec0005}
============

Fungi inflict tremendous damage to humans, other animals, and plants. Some fungal diseases are devastating to plants leading to crop destruction and enormous economic losses. Antifungal proteins have arrested the attention of investigators because of the tremendous economic implications.

To date, many different types of plant antifungal proteins are known. Among them are thaumatin-like proteins ([@bib0015], [@bib0080], [@bib0115], [@bib0175]), glucanases ([@bib0100]), chitinases and chitinases-like proteins ([@bib0040], [@bib0100]), ribosome inactivating proteins ([@bib0085]), defensins ([@bib0090], [@bib0140]), peroxidases ([@bib0150]), allergen-like proteins ([@bib0160]), protease inhibitors ([@bib0010], [@bib0160], [@bib0170]), lectins ([@bib0170]), lipid transfer proteins ([@bib0005], [@bib0130]), embryo abundant protein-like proteins ([@bib0105]), cyclophilin-like proteins ([@bib0155]), and others ([@bib0120], [@bib0125], [@bib0165]). Many of the aforementioned antifungal proteins are also referred to as pathogenesis related proteins ([@bib0095]). Antifungal proteins have also been purified from animals including insects ([@bib0020]).

The aim of the present investigation was to isolate an antifungal protein from the seeds of the cloud bean cultivar of *Phaseolus vulgaris* and to ascertain which type of antifungal protein it belongs to. Its characteristics and activities were compared with those of other antifungal proteins.

Materials and methods {#sec0010}
=====================

Isolation of antifungal protein {#sec0015}
-------------------------------

Dried seeds of *Phaseolus vulgaris* 'Cloud Bean' (250 g) from Mainland China were purchased from a vendor in Hong Kong. They were authenticated by Prof. Shiu Ying Hu, Honorary Professor of Chinese Medicine, The Chinese University of Hong Kong and then deposited in Laboratory 302, School of Biomedical Sciences, under the voucher number PVCB 195. They were homogenized in distilled water (6 ml/g) and the homogenate was centrifuged at 12 000 ×  *g* for 20 min at 4 °C. The supernatant was collected and loaded on a 5 cm × 20 cm column of DEAE-cellulose (Sigma) in 10 mM Tris--HCl buffer (pH 7.2). Following removal of unadsorbed proteins in fraction D1, adsorbed proteins were eluted from the column with 0.2 M NaCl and then with 1 M NaCl added to the 10 mM Tris--HCl buffer, to yield fractions D2 and D3, respectively. Fraction D1 was applied to a column (5 cm × 18 cm) of Affi-gel blue gel (Bio-Rad) in 10 mM Tris--HCl buffer (pH 7.2). Following elution of unadsorbed proteins in fraction B1, adsorbed proteins were desorbed initially with 0.2 M NaCl in the Tris--HCl buffer to yield fraction B2, and subsequently with 1 M NaCl in the Tris--HCl buffer to yield fraction B3. Fraction B2 was further purified by ion exchange chromatography on a column (2.5 cm × 20 cm) of SP-Sepharose (GE Healthcare) in 10 mM NH~4~OAc buffer (pH 5.0). After elution of unadsorbed proteins (fraction S1), adsorbed proteins were desorbed with a linear concentration (0--1 M) gradient of NaCl. The fraction with antifungal activity (S2) was then further fractionated by fast protein liquid chromatography on a Superdex 75 HR 10/30 column (GE Healthcare) in 0.2 M NH~4~HCO~3~ buffer (pH 8.5). The last absorbance peak (SU3) represented purified antifungal peptide.

Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) {#sec0020}
--------------------------------------------------------------------

It was conducted as described by [@bib0025] using 18% gel. Following electrophoresis under non-reducing conditions, the gel was stained with Coomassie Brilliant Blue. The molecular mass of the antifungal peptide was estimated by comparison of its electrophoretic mobility with those of molecular mass marker proteins from GE Healthcare including horse myoglobin peptides of different molecular mass: 16 949, 14 404, 10 700, 8159 and 6214 Da. The molecular mass was also determined using gel filtration on a Superdex Peptide column (GE Healthcare).

Amino acid sequence analysis {#sec0025}
----------------------------

The amino acid sequence of the antifungal peptide was analyzed by means of automated Edman degradation. Microsequencing was carried out using a Hewlett Packard 1000A protein sequencer equipped with a high performance liquid chromatography system ([@bib0035]).

Determination of protein concentration {#sec0030}
--------------------------------------

It was carried out by using the dye binding reagent (Bio-Rad).

Assay of antifungal activity {#sec0035}
----------------------------

The assay for antifungal activity toward *Mycosphaerella arachidicola*, *Physalospora piricola* and *Fusarium oxysporum* was conducted in 100 mm × 15 mm Petri plates containing 10 ml of potato dextrose agar. After the mycelial colony had developed, sterile blank paper disks (0.625 cm in diameter) were laid at a distance of 0.5 cm away from the rim of the mycelial colony. An aliquot (15 μl) of the antifungal peptide was added to a disk. The plates were then left at 23 °C for 72 h until mycelial growth had surrounded the disks containing the control and had produced crescents of inhibition around disks containing samples with antifungal activity ([@bib0110]).

To determine the IC~50~ value for the antifungal activity, three doses of the antifungal peptide were added separately to three aliquots each containing 4 ml potato dextrose agar at 45 °C, mixed rapidly and poured into three separate small Petri dishes. After the agar had cooled down, the same amount of mycelia was added to each plate. Buffer without the antifungal peptide was used as a control. After incubation at 23 °C for 72 h, the area of the mycelial colony was measured and the inhibition of fungal growth was calculated. From a graph plotting % reduction in area of mycelial colony versus concentration of antifungal peptide, the concentration bringing about 50% reduction in area of mycelial colony (IC~50~) compared with the control was determined ([@bib0140]).

Test of ability to permeabilize fungal membranes {#sec0040}
------------------------------------------------

The assay was conducted by the uptake of SYTOX Green, a high-affinity nuclear stain that penetrates cells with compromised membranes as detailed by [@bib0090]. Briefly, fungi were cultured in the presence or in the absence of cloud bean defensin. SYTOX Green (Invitrogen) was added to the fungal cultures (0.5 mM final concentration). After incubation for 10 min, the fungal cells were examined for the presence of the dye by using a fluorescence microscope (Nikon TE2000). An excitation wavelength of 500--540 nm was used.

Assay of inhibitory activity toward human immunodeficiency virus reverse transcriptase (HIV-1 RT) {#sec0045}
-------------------------------------------------------------------------------------------------

The assay was performed according to instructions provided with the assay kit from Boehringer-Mannheim (Germany). The assay makes use of the ability of reverse transcriptase to synthesize DNA, starting from the template/primer hybrid poly (A) oligo (dT) 15. The digoxigenin- and biotin-labeled nucleotides in an optimized ratio are incorporated into one of the same DNA molecule, which is freshly synthesized by the reverse transcriptase (RT). The detection and quantification of synthesized DNA as a parameter for RT activity follows a sandwich ELISA protocol. Biotin-labeled DNA binds to the surface of microtiter plate modules that have been precoated with streptavidin. Next, an antibody to digoxigenin conjugated to peroxidase binds to the digoxigenin-labeled DNA. Finally, the peroxidase substrate is added. The peroxidase enzyme catalyzes cleavage of the substrate, producing a colored reaction product. The absorbance of the samples at 405 nm, which is directly correlated to the level of RT activity, can be measured with a microtiter plate (ELISA) reader. A fixed amount (4--6 ng) of recombinant HIV-1 reverse transcriptase was used. The inhibitory activity of the isolated peptide was calculated as percent inhibition as compared to a control without the peptide ([@bib0060], [@bib0070]). The defensin gymnin ([@bib0140]) was used as a positive control.

Assay of ability to inhibit HIV-1 integrase {#sec0050}
-------------------------------------------

### Expression and purification of recombinant HIV-1 integrase {#sec0055}

The plasmid that expressed His-tagged wild-type HIV-1 integrase, pT7-7-His (Y\|TX)-HIV-1-IN, was a generous gift from Professor S.A. Chow (School of Medicine, UCLA). To express the protein, a 1-l culture of *E. coli* BL21 (DE3) cells containing the expression plasmid was grown at 37 °C until OD600 reached 0.7--0.8. Cells were induced by addition of 0.8 mM IPTG (isopropyl-β-d-thiogalactopyranoside) and harvested, after 4 h of incubation, by centrifugation at 6000 ×  *g* for 10 min at 4 °C. Cells were suspended at a concentration of 10 ml/g wet cell paste in 20 mM Tris--HCl buffer (pH 8.0) containing 0.1 mM EDTA, 2 mM β-mercaptoethanol, 0.5 M NaCl and 5 mM imidazole. Lysozyme was added to a concentration of 0.2 mg/ml. After incubation at 4 °C for 1 h, the lysate was sonicated and centrifuged at 40 000 ×  *g* at 4 °C for 20 min. The pellet was homogenized in 50 ml buffer A (20 mM Tris--HCl, pH 8.0, 2 M NaCl, 2 mM β-mercaptoethanol) containing 5 mM imidazole. The suspension was rotated at 4 °C for 1 h, and cleared by centrifugation at 40 000 ×  *g* at 4 °C for 20 min. The supernatant was loaded onto a 1-ml chelating Sepharose (GE Healthcare) column charged with 50 mM imidazole. The column was washed with five column volumes of buffer A containing 5 mM imidazole, and the protein was eluted with three column volumes of buffer A containing 200 mM and 400 mM imidazole, respectively. Protein-containing fractions were pooled, and EDTA was added to a final concentration of 5 mM. The protein was dialyzed against buffer B (20 mM HEPES, pH 7.5, 1 mM EDTA, 1 M NaCl, 20% glycerol) containing 2 mM β-mercaptoethanol, and then against buffer B containing 1 mM dithiothreitol. Aliquots of the protein were stored at −70 °C ([@bib0055]).

### HIV-1 integrase assay {#sec0060}

A non-radioactive ELISA-based HIV-1 integrase assay was performed according to the DNA-coated plate method. In this study, 1 μg of SmaI-linearized pBluescript SK was coated onto each well in the presence of 2 M NaCl as target DNA. The donor DNA was prepared by annealing VU5BR (5′-biotin-GTGTGGAAAATCTCTA-GCAGT-3′) and VU5 (5′-ACTGCTAGAGATTTTCCACAC-3′) in 10 mM Tris--HCl, pH 8.0, 1 mM EDTA and 0.1 M NaCl at 80 °C followed by 30 min at room temperature. Integrase reaction was performed in 20 mM HEPES (pH 7.5) containing 10 mM MnCl~2~, 30 mM NaCl, 10 mM dithiothreitol and 0.05% Nonidet-P40 (Sigma). After the integrase reaction, the biotinylated DNA immobilized on the wells was detected by incubation with streptavidin-conjugated alkaline phosphatase (Boehringer-Mannheim, Mannheim, Germany), followed by colorimetric detection with 1 mg/ml p-nitrophenyl phosphate in 10% diethanolamine buffer (pH 9.8) containing 0.5 mM MgCl~2~. The absorbance due to the alkaline phosphatase reaction was measured at 415 nm. The ribosome inactivating protein trichosanthin was used as a positive control ([@bib0055]).

Assay of antiproliferative activity {#sec0065}
-----------------------------------

The antiproliferative activity of the purified peptide was determined as follows. The cell lines L1210 (mouse leukemia) and MBL2 (lymphoma) from American Type Culture Collection were maintained in Dulbecco Modified Eagles' Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 100 mg/l streptomycin and 100 IU/ml penicillin, at 37 °C in a humidified atmosphere of 5% CO~2~. Cells (1 × 10^4^) in their exponential growth phase were seeded into each well of a 96-well culture plate (Nunc, Denmark) and incubated for 3 h before addition of the peptide. Incubation was carried out for another 48 h. Radioactive precursor, 1 μCi, \[methyl-^3^H\] thymidine (GE Healthcare) was added to each well and incubated for 6 h. The cultures were then harvested by a cell harvester. The incorporated radioactivity was determined by liquid scintillation counting ([@bib0140]).

Screening for inhibitory effect on SARS coronavirus protease {#sec0070}
------------------------------------------------------------

The activity of SARS coronavirus (CoV) protease was indicated by a cleavage of designed substrate which was composed of two proteins linked by a cleavage site for SARS CoV protease. The reaction was performed in a mixture containing 5 μM SARS CoV protease, 5 μM sample, 20 μM substrate and buffer \[20 mM Tris--HCl (pH 7.5), 20 mM NaCl and 10 mM beta-mercaptoethanol\] for 40 min at 37 °C. After 40 min, the reaction was stopped by heating at 100 °C for 2 min. Then the reaction mixture was analysed by SDS-PAGE. If SARS CoV protease is inhibited by the test sample, there is only one band, which is the intact substrate, shown in SDS-PAGE ([@bib0045]).

Results {#sec0075}
=======

Isolation of defensin {#sec0080}
---------------------

The extract of cloud beans was fractionated into three fractions of approximately equal size: an unadsorbed fraction D1 with antifungal activity and two adsorbed fractions D2 and D3 without activity ([Table 1](#tbl0005){ref-type="table"} ). Fraction D1 was resolved on Affi-gel blue gel into a larger unadsorbed fraction B1 devoid of antifungal activity, an adsorbed fraction B2 with antifungal activity eluted with 0.2 M NaCl in the Tris--HCl buffer, and an adsorbed fraction B3 eluted with 1.0 M NaCl in the Tris--HCl buffer but without antifungal activity ([Table 1](#tbl0005){ref-type="table"}). Fraction B2 was separated on SP-Sepharose into a broad unadsorbed fraction S1 and three sharp adsorbed fractions S2, S3 and S4 ([Fig. 1](#fig0005){ref-type="fig"} ). Antifungal activity was detected only in the largest fraction S2 ([Table 1](#tbl0005){ref-type="table"}). Fraction S2 was separated by gel filtration on Superdex 75 into three fractions SU1, SU2 and SU3 ([Fig. 2](#fig0010){ref-type="fig"} ). SU3, which displayed a molecular mass of 7.3 kDa, was the only fraction with antifungal activity ([Table 1](#tbl0005){ref-type="table"}). Its amino acid sequence, which manifests pronounced homology to plant defensins, is recorded in [Table 2](#tbl0010){ref-type="table"} . Fraction SU3 appeared in SDS-PAGE as a single band with a molecular mass of 7.3 kDa ([Fig. 3](#fig0015){ref-type="fig"} ).Table 1Yields and antifungal potencies (toward *M. arachidicola*) of various chromatographic fractions derived from 250 g cloud beans.ColumnChromatographic fractionYield (mg)IC~50~ (μg/ml)DEAE-cellulose**D1 unadsorbed**[a](#tblfn0005){ref-type="table-fn"}**1561302.7**D2 adsorbed1092--D3 adsorbed1224--  Affi-gel blue gelB1 unadsorbed600--**B2 adsorbed31083.9**B3 adsorbed247--  S-SepharoseS1 unadsorbed23--**S2 adsorbed10236.5**S3 adsorbed49--S4 adsorbed58--  Superdex 75SU123--SU219--**SU33013.1**[^1]Fig. 1Ion exchange chromatography of fraction B2 (from Affi-gel blue gel column) on SP-Sepharose. Column dimensions: 2.5 cm × 20 cm. Starting buffer: 10 mM NH~4~OAc buffer (pH 5.0). Slanting line across right half of chromatogram represents the linear 0--1 M NaCl gradient included in the 10 mM NH~4~OAc buffer used to elute adsorbed proteins.Fig. 2Gel filtration by FPLC on a Superdex 75 HR 10/30 column. Buffer: 0.2 M NH~4~HCO~3~ (pH 8.5). Flow rate: 0.4 ml/min. Fraction size: 0.8 ml. Sample: Fraction S2 from SP-Sepharose column chromatography.Table 2N-terminal amino acid sequence (1--40) of *Phaseolus vulgaris* 'Cloud Bean' defensin in comparison with related legume defensins.SpeciesN-terminal amino acid sequence (1--40)*Phaseolus vulgaris* 'Cloud Bean'KTYENLADTYKGPYFTTGSHDDHYKNKEHLRSGRYRDDFF*Clitora ternatea*NLCERASLTWTGNCGNTGHCDTQCRNWESAKHGACHKRGN*Phaseolus vulgaris* cv. 'White Cloud Bean'KTCENLADTFRGPCFATSNCDDHCKNKEHLLSGRCRDDFR*Pisum sativum*NTCENLAGSYKGVCFGGCDRHCRTQEGAISGRCRDDFRCW*Vicia faba*LLGRCKVKSNRFNGPCLTDTHCSTVCRGEGYKGGDCHGLR*Vigna radiata* D1ANCKTESMTFPGICITKPPCEKALISNKFTDGNCSKILEE*Vigna radiata* Ph1ATCKAECFTWDEVCINKKFCVACCEKAEFSDGNCSKILEK*Vigna unguiculata*KTCENLVDTYRGPCFTTGSCDDHCKNKEHLLSGRCRDDFRFig. 3SDS-polyacrylamide gel electrophoresis of fraction SU3 (from Superdex 75 column chromatography). Left lane: molecular mass marker from GE Healthcare. Right lane: fraction SU3 (purified cloud bean antifungal peptide).

Biological activities of isolated defensin {#sec0085}
------------------------------------------

The inhibitory action of the purified antifungal peptide represented by fraction SU3 on the fungi *Mycosphaerella arachidicola* and *Fusarium oxysporum* is shown in [Fig. 4](#fig0020){ref-type="fig"}, [Fig. 5](#fig0025){ref-type="fig"} , respectively. There was a dose-dependent inhibition of mycelial growth. The antifungal peptide suppressed mycelial growth in *M. arachidicola* with an IC~50~ value of 1.8 μM ([Fig. 6](#fig0030){ref-type="fig"} ) and *Fusarium oxysporum* with an IC~50~ value of 2.2 μM. The antifungal peptide did not reduce the activity of HIV-1 reverse transcriptase. Neither did it affect the activities of HIV-1 integrase and SARS coronavirus proteinase (data not shown). But it inhibited the proliferation of L1210 and MBL2 tumor cells with an IC~50~ of 1.0 μM and 40 μM, respectively ([Table 3](#tbl0015){ref-type="table"} ). In the assay of SYTOX Green uptake, cloud bean defensin (10 μM) could induce membrane permeabilization in *M. arachidicola* and *F. oxysporum* as evidenced by staining of the nuclei (data not shown, but similar to results of [@bib0135], [@bib0145], [@bib0050]).Fig. 4Antifungal activity of purified antifungal peptide toward *Mycosphaerella arachidicola*. (A) Control, 15 μl 50 mM MES buffer (pH 6.0). (B) 12 μg peptide in 15 μl MES buffer. (C) 2.4 μg peptide in 15 μl MES buffer.Fig. 5Antifungal activity of purified antifungal peptide toward *Fusarium oxysporum*. (A) Control, 15 μl 50 mM MES buffer (pH 6.0). (B) 12 μg peptide in 15 μl MES buffer. (C) 2.4 μg peptide in 15 μl MES buffer.Fig. 6Determination of IC~50~ value of antifungal activity of purified antifungal peptide toward *Mycosphaerella arachidicola*. (A) 0 μM antifungal peptide. (B) 0.6 μM antifungal peptide. (C) 3 μM antifungal peptide. (D) 15 μM antifungal peptide. The IC~50~ value was determined to be 1.8 μM.Table 3Antiproliferative activity (inhibition rate) of 'Cloud Bean' defensin toward L1210 and MBL2 tumor cells. Results are presented as mean ± SD (*n* = 3).Dose (μM)%Inhibition of \[methyl-^3^H\] thymidine incorporationL1210 cells MBL2 cells4098.2 ± 3.650.1 ± 3.32097.8 ± 3.821.7 ± 2.61094.6 ± 3.56.6 ± 0.7588.5 ± 4.1--2.577.3 ± 2.8--1.363.5 ± 3.2--0.728.9 ± 1.9--  IC~50~ (μM)1.040

Comparison with white cloud bean defensin {#sec0090}
-----------------------------------------

[Table 4](#tbl0020){ref-type="table"} presents a comparison of the characteristics and activities of cloud bean defensin with white cloud bean defensin. They are grossly similar.Table 4Comprison of biochemical characteristics and activities of defensins from *Phaseolus vulgaris* cv. 'Cloud Bean' and *Phaseolus vulgaris* cv. 'White Cloud Bean'.Cloud bean defensinWhite cloud bean defensinMolecular mass (kDa)7.37.4Chromatographic behavior on Affi-gel blue gelAdsorbedAdsorbed DEAE-celluloseUnadsorbed-- SP-SepharoseAdsorbed--Antifungal activity (IC50) *Fusarium oxysporum*2.2 μM2.3 μM *Mycosphaerella arachidicola*1.8 μM0.7 μM *Botrytis cinerea*--2.8 μMAntiproliferative activity (IC~50~) L121010 μM-- MBL240 μM-- MCF75.7 μMHIV-1 reverse transcriptase inhibitory avtivity (IC~50~)No activity at 100 μM120 μM

Discussion {#sec0095}
==========

The antifungal peptide isolated from cloud beans in the present study is a defensin as judged by the remarkable homology of its N-terminal amino acid sequence to plant defensins ([@bib0090]). It has a molecular mass and chromatographic behavior on cationic and anionic exchangers and Affi-gel blue gel similar to those of plant defensins reported earlier. It is unadsorbed on DEAE-cellulose but adsorbed on SP-Sepharose and Affi-gel blue gel. This chromatographic behavior is also characteristic of antifungal proteins in general ([@bib0040], [@bib0105], [@bib0115], [@bib0125], [@bib0120], [@bib0130], [@bib0140], [@bib0160], [@bib0170], [@bib0165], [@bib0175], [@bib0150], [@bib0155]).

Cloud bean defensin potently inhibits proliferation of tumor cells. Antiproliferative activity toward tumor cells is also an attribute of defensins ([@bib0140]), defensin-like peptides and also other antifungal proteins including ribosome inactivating proteins ([@bib0035]) and chitinase-like proteins ([@bib0040]). This activity of cloud bean defensin may be a consequence of the protein synthesis inhibitory activity which is a characteristic of antifungal proteins ([@bib0075]) including ribosome inactivating proteins ([@bib0065]). It is noteworthy that cloud bean defensin is inhibitory to both L1210 and MBL2 tumor cells. The antifungal protein passiflin ([@bib0030]) inhibits proliferation in breast cancer MCF7 cells, but not in hepatoma HepG2 cells.

Some antifungal proteins including defensin-like peptides ([@bib0140]), protease inhibitors ([@bib0160]), thaumatin-like proteins ([@bib0115]), chitinase-like proteins ([@bib0040]) and ribosome inactivating proteins ([@bib0135], [@bib0145]) demonstrate HIV-1 reverse transcriptase inhibitory activity. It is somewhat surprising that cloud bean defensin is devoid of inhibitory activity toward the retroviral enzyme. Its lack of inhibition on HIV-1 integrase and SARS coV protease is in concord with previous reports on other defensins ([@bib0045]).

The present findings on cloud bean defensin is reminiscent of the observation that mungin, an antifungal protein from mung beans, is without HIV-1 reverse transcriptase inhibitory activity ([@bib0155]). The isolated defensin-like antifungal peptide potently inhibits fungal growth in both fungal species examined. Some antifungal proteins are able to inhibit only one out of the several fungi tested ([@bib0110]). Other antifungal proteins have a lower antifungal potency than cloud bean defensin ([@bib0175]).

To recapitulate, a defensin with potent antifungal, and antiproliferative activities was isolated from cloud beans. Like French bean defensin ([@bib0045]), it is devoid of inhibitory activity toward HIV-1 integrase and SARS coronavirus proteinase.

White cloud bean and cloud bean are two cultivars of *Phaseolus vulgaris*. Their defensins are similar in molecular mass, N-terminal sequence and antifungal potency. However, white cloud bean defensin, but not cloud bean defensin, has inhibitory activity toward HIV-1 reverse transcriptase. The former appears to be more potent in inhibitory activity toward tumor cells. Hence similar, but not identical proteins are produced by different cultivars.
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[^1]: Defensin-enriched fractions are highlighted in boldface.
